AI in healthcare insights: 11th December - 17th December


 

1. Large-language-model-driven screening accelerates liver-cancer evidence synthesis.

Keeping up with the latest research on liver cancer treatment is a massive task for medical experts. Primary liver cancer, specifically hepatocellular carcinoma (HCC), evolves quickly, making it incredibly difficult for clinical guidelines to stay current. Researchers have now successfully tested an automated system using Large Language Models (LLMs) to solve this bottleneck. This AI tool acts like a super-speed reader, scanning through thousands of medical study abstracts to identify relevant evidence for treatment guidelines much faster than any human team could manage.

In rigorous testing, this AI workflow proved highly effective, achieving a screening accuracy of 96%. It significantly slashed the time and financial cost required to review medical literature without missing critical data points. While human oversight is still necessary to catch subtle context errors, this technology promises to accelerate how quickly new scientific discoveries translate into patient care. By streamlining the evidence review process, the medical community can ensure that liver cancer treatments are always based on the very latest science.

Read the original article at: https://medinform.jmir.org/2025/1/e76252

2. AI model predicts infection risk from oral mucositis in transplant patients.

For patients fighting blood cancers like leukemia, stem cell transplants can be life-saving, but they come with severe risks. One common and painful side effect is oral mucositis, which causes open sores in the mouth. New research has quantified a frightening reality: transplant patients with these sores are nearly four times more likely to develop severe, life-threatening infections. The mouth sores effectively act as an open door for bacteria to enter the bloodstream of patients whose immune systems are already weak.

To combat this, researchers have developed a new Artificial Intelligence tool that predicts which patients are most at risk before treatment begins. By analyzing factors like age, gender, and specific medications, the AI creates a personalized risk profile. This allows doctors to take preventive steps early, such as using special ice therapies or oral hygiene protocols. This "explainable AI" not only flags high-risk patients but also explains why, giving doctors the confidence to intervene and potentially save lives.

Read the original article at: https://medicalxpress.com/news/2025-09-tool-infection-oral-mucositis-poses.html

3. 3D bioprinter with AI ‘vision’ co-designs tissues, boosting cell survival.

3D printing living tissue is one of the most exciting frontiers in medicine, offering hope for replacing damaged organs. However, it is notoriously difficult because living cells are fragile and often die during the printing process. Researchers at Utrecht University have made a breakthrough by turning the printer into an intelligent partner. Their new system, called GRACE, uses Artificial Intelligence and cameras to "see" what it is printing in real-time and adjust its design on the fly to protect the cells.

Unlike traditional printers that blindly follow a pre-set blueprint, this AI-driven machine observes the exact location of cells and builds the structure around them. This "co-design" approach ensures that blood vessel networks are placed exactly where they are needed to keep the tissue alive. The result is a dramatic improvement in cell survival and tissue functionality. This innovation brings scientists much closer to the dream of printing fully functional bone, heart, or liver tissues for successful transplantation into patients.

Read the original article at: https://www.uu.nl/en/news/ai-turns-printer-into-a-partner-in-tissue-engineering

4. Addiction care enters AI era: relapse risk, personalised treatment and monitoring.

The field of addiction medicine is beginning to embrace Artificial Intelligence to improve recovery outcomes for patients with substance use disorders. Historically, predicting when a patient might relapse has been difficult, leaving doctors to react only after a setback occurs. Now, AI models are changing this by analyzing behavioral patterns to predict relapse risks before they happen. This allows therapists to intervene earlier, offering support precisely when the patient is most vulnerable, rather than waiting for a crisis.

Beyond risk prediction, these digital tools are helping to personalize treatment plans. AI can analyze a patient's medical history and social factors to recommend the specific therapies that are most likely to work for them. While the human connection remains the heart of addiction recovery, these smart tools act as a powerful assistant. By providing data-driven insights, AI empowers clinicians to tailor their care, potentially increasing the long-term success rates for individuals fighting to overcome addiction.

Read the original article at: https://aiin.healthcare/topics/artificial-intelligence/addiction-medicine-eager-embrace-ai

5. AI tools integrate data sources to predict chronic-kidney-disease progression earlier.

Chronic Kidney Disease (CKD) is a silent condition that often worsens unpredictably, leading to kidney failure that requires dialysis or a transplant. Doctors have long struggled to accurately predict which patients will progress to this severe stage. Researchers from Carnegie Mellon University have developed a new AI model that significantly outperforms current prediction methods. Unlike standard tests that look at limited factors, this AI analyzes a wide range of data, including medical images and clinical notes, to spot warning signs.

This "multimodal" approach allows the AI to see the full picture of a patient's health. It can identify subtle patterns indicating a decline in kidney function up to five years in advance. This early warning system is a game-changer for nephrologists. By identifying high-risk patients years earlier, doctors can start aggressive treatments sooner to slow the disease down. This technology could delay or even prevent the need for life-altering dialysis, vastly improving quality of life for millions.

Read the original article at: https://medicalxpress.com/news/2025-09-ai-chronic-kidney-disease-stage.html

6. Drone-delivered defibrillators and AI logistics could reshape cardiac-arrest response.

When someone suffers a cardiac arrest, every second counts, and waiting for an ambulance can sometimes take too long. A new study in the UK is testing a futuristic solution: using drones to fly defibrillators directly to the scene of an emergency. Researchers at the University of Warwick successfully demonstrated that drones could carry these life-saving devices to remote locations faster than road ambulances. In simulated emergencies, the drones arrived quickly, and members of the public were able to retrieve and use the equipment.

The study highlights how logistics and technology can reshape emergency response. While the drones flew autonomously and safely, the research also found that bystanders need clear guidance to feel confident using the machine. This "air delivery" system aims to bridge the gap between a 999 call and the arrival of paramedics. By ensuring a defibrillator is on-site within minutes, this technology has the potential to significantly boost survival rates for out-of-hospital cardiac arrests.

Read the original article at: https://interestingengineering.com/innovation/uk-drones-defibrillators-cardiac-arrest-study

 

Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

Comments

Post a Comment

Popular posts from this blog

Generative AI Will Transform Healthcare, But Only If We Get the Governance Right

Image
  India is entering a more serious phase of healthcare AI. With ABDM’s digital rails in place, and policy and governance frameworks beginning to take shape, the country is now better positioned to use generative AI at scale. This is no longer just a future idea. It is already entering real workflows such as consultation summaries, discharge drafts, coding support, patient communication, and claims documentation. That makes the conversation more urgent. In healthcare, the real question is not whether generative AI is impressive, but whether it can be trusted in systems where errors have clinical, operational, financial, and legal consequences. AI will shape healthcare meaningfully only if governance is built in from the start, not added later as an afterthought. The opportunity is real The case for generative AI in healthcare is strong. It can reduce administrative burden, improve documentation quality, support coding and claims workflows, simplify patient communication, and help cl...
Read more

AI in healthcare Insights: 20th November - 26th November' 2025

Image
  Gel-free 3D-printed electrodes + AI detect arrhythmias in wearables Researchers at Simon Fraser University have developed a heart monitoring system combining 3D printing and AI to improve cardiac diagnostics. The system uses reusable, dry 3D-printed electrodes with an origami-inspired design that adheres to the skin without sticky gel, addressing issues of patient discomfort and signal degradation over time.  The embedded AI software is capable of pre-diagnosing up to 10 types of arrhythmias in real-time. Clinical testing indicates the design improves patient compliance compared to traditional Holter monitors. The system is designed to allow test results to be shared electronically with physicians for confirmation, aiming to expand access to monitoring in remote and underserved communities. Read the original article at https://www.sfu.ca/sfunews/media/media-releases/2025/11/ai-at-the-heart-of-new-sfu-gel-free-ecg-system-for-faster-diagno.html Our Opinion: This shift solve...
Read more

Clinical AI & MedTech Insights: January 22 - January 28

Image
  UK trust tests AI safety and fairness across all patients As artificial intelligence tools become common in hospitals ensuring they work equally well for everyone is critical. The University Hospitals of Leicester has launched a major trial to assess the fairness of AI diagnostic models across diverse patient groups. The study aims to identify and mitigate algorithmic bias where AI performs well for one demographic but fails for another. This often happens when models are trained on narrow datasets that do not represent the full population. By rigorously testing these tools on a wide range of real world patient data the trust hopes to set a new standard for safe and equitable deployment. This initiative addresses the growing concern that medical AI could inadvertently worsen health disparities if left unchecked. The ultimate goal is to validate that these powerful diagnostic aids deliver the same high level of accuracy for every patient regardless of their background or medic...
Read more